DSP Banking & Financial Services Fund - Direct - Growth vs Nippon India Pharma Fund-Growth Plan-Bonus Option
Side-by-side comparison of NAV, returns, expense ratio and star rating.
TopFund Analysis
The DSP Banking & Financial Services Fund - Direct - Growth appears stronger on the star rating with a 4-star rating compared to Nippon India Pharma Fund's 2-star rating, indicating a potentially better quality of management or performance. However, while DSP offers a lower expense ratio of 0.79%, Nippon India Pharma Fund has higher 1-year returns at 11.76% and impressive 3-year and 5-year CAGR figures of 16.54% and 13.76%, respectively, suggesting a tradeoff between higher returns and higher expense ratio. For investors choosing between them, the decision may hinge on whether they prioritize higher recent returns or a more favorable star rating.
DSP Banking & Financial Services Fund - Direct - Growth
DSP Mutual Fund
★★★★★
Equity · Sectoral Fund
Nippon India Pharma Fund-Growth Plan-Bonus Option
Nippon India Mutual Fund
★★★★★
Equity · Sectoral Fund
| Metric | DSP Banking & Financia... | Nippon India Pharma Fu... |
|---|---|---|
| NAV | ₹15.89 | ₹582.42 |
| Star Rating | ★★★★ | ★★ |
| Expense Ratio | 0.79% | 0.99% |
| AUM | ₹2,034 Cr | ₹9,166 Cr |
| 1M Return | +8.06% | +8.53% |
| 3M Return | +1.24% | +2.09% |
| 6M Return | +10.45% | +6.88% |
| 1Y Return | +10.66% | +11.76% |
| 3Y CAGR | — | +16.54% |
| 5Y CAGR | — | +13.76% |
| Risk Level | — | — |
| Fund Manager | Dhaval Gada | Sailesh Raj Bhan |